The Celli Lab

University of Massachusetts Boston
Department of Physics

Funding

We gratefully acknowledge current and previous funding.

Current support

  1. NIH/NCI U01CA279862 (PIs: Celli, Hasan, Liang): A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings.
  2. NSF 2301804 (PI: Dahl): Investigating the Continuum of Cell Spheroid Biomechanical Behavior with Spheroid Size. (Role: co-I)
  3. NIH/NCI U54CA156734 (embedded project): Photodynamic activation of antitumor immunity with real-time imaging-based feedback for targeting health disparities in oral cancer. (Role: Project co-PI)
  4. NIH/NCI SBIR 75N91024C00085 (subcontract from Light Research Inc., PI: Wilder-Smith): Mobile Oral-Cancer Screening and Treatment (MOST) System for Low-Resource Settings. (Role: Co-Investigator)
  5. NSF 2523750 (PI: Celli): I-Corps: Translation potential of technology for image-guided photodynamic treatment of oral potentially malignant lesions.

Previous support

  1. UMass President's Office, OTCV Technology Development Award: A Smartphone-controlled Battery-powered Portable Medical Device for Intraoral Photodynamic Therapy.
  2. NIH/NCI U54CA156734: Development of synergistic light-activated and anti-microRNA combination therapies for pancreatic ductal adenocarcinoma.
  3. NSF 1843101, STTR Phase 1: Flexible Quantum Dot Light Emitting Devices for Photodynamic Therapy and Photobiomodulation. (Role: co-I)
  4. NIH/NCI UH3CA189901: Low-cost Enabling Technology for Image-Guided Photodynamic Therapy of Oral Cancer.
  5. NIH/NCI K99/R00 CA155045: "Mechanism-based therapies for pancreatic cancer informed by stromal microrheology."
  6. NIH/NCI UH2CA189901: "Low-cost enabling technology for image-guided photodynamic therapy of oral cancer."
  7. UMass Boston, Joseph P. Healey Grant: High-Throughput Microfluidics-based Characterization of Cells to Inform Cancer Therapeutics.
  8. NIH/NCI U54CA156734: Development of novel anti-microRNA and photomedicine combination therapies for pancreatic cancer using patient-derived organoid co-culture models.
  9. UMass Boston, Joseph P. Healey Grant: Stochastic Modeling of Phenotypic Switching and Chemoresistance in Cancer Cell Populations.